Journal of Clinical Pediatrics ›› 2026, Vol. 44 ›› Issue (1): 71-78.doi: 10.12372/jcp.2026.25e0928

• Literature Review • Previous Articles     Next Articles

Advances in risk factors and novel biomarkers for neonatal acute kidney injury

ZHANG Wenjing1,2, WANG Fan1,2, ZHANG Li1,2, LI Lan3()   

  1. 1. Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu 610041, Sichuan, China
    2. Key Laboratory of Birth Defects and Related Diseases of Women and Children, Chengdu 610041, Sichuan, China
    3. Department of Pediatrics, Sichuan Academy of Medical Sciences Sichuan Provincial People's Hospital, Chengdu 610072, Sichuan, China
  • Received:2025-07-31 Accepted:2025-10-22 Published:2026-01-15 Online:2026-01-05

Abstract:

Neonatal acute kidney injury (AKI) predominantly occurs in critically ill infants, with an incidence rate of approximately 30% in neonatal intensive care units. It is associated with a significantly increased risk of mortality and a high propensity to progress to chronic kidney disease. This review mainly summarizes recent advances in the risk factors and emerging biomarkers for neonatal AKI. Besides, this review summarizes the clinical characteristics associated with different risk factors and the sensitivity and specificity of corresponding biomarkers. The occurrence of neonatal acute kidney injury is characterized by multifactorial interactions, and the pathological mechanisms vary depending on the underlying risk factors. The use of specific biomarkers facilitates early diagnosis and precise intervention. Combined monitoring of risk factors and biomarker levels enables early identification of acute kidney injury, guiding individualized treatment and prognosis assessment.

Key words: acute kidney injury, risk factor, biomarker, neonate

CLC Number: 

  • R72